Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Patient Safety topic
No spam. Unsubscribe anytime.
Members press CCA for better adverse-event tracking and ED data as adult-use rollout nears
Summary
Council members urged the CCA to expand systematic adverse-event tracking and to coordinate with health departments on emergency-department visit data; CCA said it receives complaints and will work to build more intentional surveillance systems.
Council members asked whether the state is collecting data on negative outcomes tied to medical cannabis, emergency-department visits and complaints about practitioners. David Brown and other department representatives confirmed that health systems record cannabis-related ED visits and hospitalizations; CCA staff said their current data collection is limited but they receive and investigate patient complaints.
"We don't have any specific data on that," a CCA representative said when asked about negative sequelae reported by patients, adding that complaints are handled case-by-case and that the authority plans to build more intentional systems for tracking adverse events as retail sales expand. Members suggested a future meeting focused on ED visit trends and that the council consider soliciting reports from health departments and hospitals.
The council also discussed practitioner availability and telehealth follow-up; staff said they had added language to certification forms that practitioners agree to be available for follow-up and that the CCA could report problematic practitioners to relevant licensing boards if necessary. Members emphasized pharmacists' patient-consultation role in dispensaries as an immediate mitigation step while surveillance is strengthened.
